Encompass Health Corp (NYSE:EHC) has earned an average broker rating score of 1.90 (Buy) from the ten brokers that provide coverage for the company, Zacks Investment Research reports. Four investment analysts have rated the stock with a hold recommendation, one has given a buy recommendation and five have issued a strong buy recommendation on the company. Encompass Health’s rating score has improved by 0.5% from 90 days ago as a result of a number of analysts’ ratings changes.
Brokers have set a 1 year consensus price objective of $54.10 for the company and are anticipating that the company will post $0.77 earnings per share for the current quarter, according to Zacks. Zacks has also given Encompass Health an industry rank of 134 out of 265 based on the ratings given to its competitors.
Several research analysts recently commented on EHC shares. Bank of America raised shares of Encompass Health from an “underperform” rating to a “neutral” rating in a report on Thursday, January 4th. ValuEngine raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Monday, February 5th. Craig Hallum reaffirmed a “buy” rating and issued a $60.00 price objective (up from $54.00) on shares of Encompass Health in a report on Tuesday, January 9th. Finally, Credit Suisse Group reaffirmed an “outperform” rating on shares of Encompass Health in a report on Tuesday.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 16th. Investors of record on Monday, April 2nd will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 1.88%. The ex-dividend date is Thursday, March 29th. Encompass Health’s dividend payout ratio (DPR) is presently 37.31%.
ILLEGAL ACTIVITY WARNING: “Zacks: Encompass Health Corp (EHC) Given Average Recommendation of “Buy” by Brokerages” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://www.tickerreport.com/banking-finance/3229270/zacks-encompass-health-corp-ehc-given-average-recommendation-of-buy-by-brokerages.html.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.